Infliximab therapy in two cases of severe neurotuberculosis paradoxical reaction

Med J Aust. 2015 Feb 16;202(3):156-7. doi: 10.5694/mja14.00716.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / therapeutic use*
  • Antibodies, Monoclonal / therapeutic use*
  • Antitubercular Agents / therapeutic use*
  • Dexamethasone / therapeutic use
  • Ethambutol / therapeutic use
  • Female
  • Humans
  • Infliximab
  • Isoniazid / therapeutic use
  • Middle Aged
  • Prednisolone / therapeutic use
  • Pyrazinamide / therapeutic use
  • Rifampin / therapeutic use
  • Tuberculoma, Intracranial / drug therapy*
  • Tuberculosis, Meningeal / drug therapy*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Antitubercular Agents
  • Tumor Necrosis Factor-alpha
  • Pyrazinamide
  • Dexamethasone
  • Ethambutol
  • Prednisolone
  • Infliximab
  • Isoniazid
  • Rifampin